By proceeding, you agree to our Terms of Use and Privacy Policy.
Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development.
08-09 February 2022
The SmartLab Exchange brings together a select group of leading experts from across the smart laboratory space for innovative learning and thought-leadership discussions.
Event Ended
Germany
Paid
Berlin
28-30 March 2022
The 10th Neurodegenerative Disease Drug Development Summit will be discussing, debating and exploring pivotal neurodegenerative disease research from the past 12 months.
USA
Boston
11-13 September 2022
RAPS Convergence is the largest and most well-recognized annual gathering of regulatory professionals and innovators in the world.
Phoenix
20-22 September 2022
Bringing together the greater medical affairs community to collaborate and share best practices MASS West 2022 will provide a platform for Medical Affairs executives and professionals to share best practices, strategic insights, and collaborate to ad
San Diego
28-29 September 2022
The most influential forum for Japanese pharma leaders in Marketing, Commercial, Medical Affairs, RWE, and Clinical Pharma has entered a new world, where scientific innovation is no longer enough to be successful.
Japan
Meguro City
18-20 October 2022
The 3rd Annual Gene Therapy Immunogenicity Summit is industry’s definitive forum enabling you to better modulate, measure and predict the immune response to your gene therapy candidate.
16-18 May 2023
The Bio-IT World Conference & Expo is the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. For over 20 years, the Event has united a communi
23-27 August 2023
The International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE 2023) will be held in Halifax, Nova Scotia, Canada from August 23-27, 2023. The conference is organized by the International Society for Pharmacoepidemiology (IS
Hybrid
Halifax
05-07 September 2023
Developing safe and effective gene therapies using AAV vectors is hindered by challenges related to the immune response. However, over the past two decades, drug developers have identified and are working on solutions to various immune responses to A